✦ LIBER ✦

11 Efficacy of standard-dose and fixed-dose induction peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) among pegylated interferon alpha-2b (12kd)/ribavirin non-responders: Interim analysis of the repeat study

✍ Scribed by P. Marcellin; G. Teuber; V. Canva; O. Weiland; A. Di Bisceglie; C. Brandao-Mello; B. Freilich; D. Jensen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

583 Safety of peginterferon α-2a (40KD)

✍ D. Jensen; F. Andreone; Y. Benhamou; Y. Horsmans; M. Diago; A. Olveira Martins; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 234 KB

575 Retreatment with peginterferon α-2a

✍ N. Gitlin; D. Jensen; A. Di Bisceglie; T. Berg; J. Salmeron; M. Rizzetto; C. Yur 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 247 KB

P.259 Retreatment with peginterferon alp

✍ P. Marcellin; G. Teuber; B. Freilich; O. Weiland; A. Di Bisceglie; C. Brandao-Me 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 119 KB

566 Pharmacokinetics and pharmacodynamic

✍ M. Diago; M. Romero-Gomez; J. Crespo; A. Olveira; R. Perez; R. Barcena; J.M. San 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 265 KB